SMAD2 and myeloid sarcoma: However, in CD, we found downregulation of SMAD2, SMAD3, and SMAD4, in addition to SMAD7, probably owing to more pronounced downregulation of SMAD transcription in CD than in MS, although this hypothesis requires further investigation.